Literature DB >> 10997127

Mild cognitive impairment. When is it a precursor to Alzheimer's disease?

Y Shah1, E G Tangalos, R C Petersen.   

Abstract

There is good evidence suggesting that onset of Alzheimer's disease is commonly preceded by an interim phase known as mild cognitive impairment (MCI). Persons who experience this condition are at increased risk for the development of Alzheimer's disease. Diagnosing MCI involves excluding other morbidities and determining whether the patient meets predefined assessment criteria. There is no treatment for the prevention of MCI, but an understanding of the condition can improve patient management. Several clinical trials are underway to investigate potential potential MCI agents.

Entities:  

Mesh:

Year:  2000        PMID: 10997127

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  15 in total

Review 1.  Eye movements in Alzheimer's disease.

Authors:  Robert J Molitor; Philip C Ko; Brandon A Ally
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery.

Authors:  Jane B Tornatore; Emory Hill; Jo Anne Laboff; Mary E McGann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

3.  MEG spectral analysis in subtypes of mild cognitive impairment.

Authors:  M E López; P Cuesta; P Garcés; P N Castellanos; S Aurtenetxe; R Bajo; A Marcos; M L Delgado; P Montejo; J L López-Pantoja; F Maestú; A Fernandez
Journal:  Age (Dordr)       Date:  2014-02-16

4.  Relationship between Brain Tissue Changes and Blood Biomarkers of Cyclophilin A, Heme Oxygenase-1, and Inositol-Requiring Enzyme 1 in Patients with Alzheimer's Disease.

Authors:  Hyon-Il Choi; Kiyoon Kim; Jiyoon Lee; Yunjung Chang; Hak Young Rhee; Soonchan Park; Woo-In Lee; Wonchae Choe; Chang-Woo Ryu; Geon-Ho Jahng
Journal:  Diagnostics (Basel)       Date:  2021-04-21

5.  Phytopharmacologic aspects of Canscora decussata Roem and Schult.

Authors:  Neeraj K Sethiya; M B Patel; S H Mishra
Journal:  Pharmacogn Rev       Date:  2010-01

6.  How to Build a Functional Connectomic Biomarker for Mild Cognitive Impairment From Source Reconstructed MEG Resting-State Activity: The Combination of ROI Representation and Connectivity Estimator Matters.

Authors:  Stavros I Dimitriadis; María E López; Ricardo Bruña; Pablo Cuesta; Alberto Marcos; Fernando Maestú; Ernesto Pereda
Journal:  Front Neurosci       Date:  2018-06-01       Impact factor: 5.152

7.  The usefulness of the Korean version of modified Mini-Mental State Examination (K-mMMSE) for dementia screening in community dwelling elderly people.

Authors:  Seul-Ki Jeong; Ki-Hyun Cho; Jae-Min Kim
Journal:  BMC Public Health       Date:  2004-07-30       Impact factor: 3.295

8.  Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Clive Beggs; Chih-Ping Chung; Niels Bergsland; Pei-Ning Wang; Simon Shepherd; Chun-Yu Cheng; Michael G Dwyer; Han-Hwa Hu; Robert Zivadinov
Journal:  BMC Neurol       Date:  2013-10-31       Impact factor: 2.474

9.  Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.

Authors:  Hyug-Gi Kim; Soonchan Park; Hak Young Rhee; Kyung Mi Lee; Chang-Woo Ryu; Sun Jung Rhee; Soo Yeol Lee; Yi Wang; Geon-Ho Jahng
Journal:  Neuroimage Clin       Date:  2017-08-24       Impact factor: 4.881

10.  MEG Beamformer-Based Reconstructions of Functional Networks in Mild Cognitive Impairment.

Authors:  Maria E López; Marjolein M A Engels; Elisabeth C W van Straaten; Ricardo Bajo; María L Delgado; Philip Scheltens; Arjan Hillebrand; Cornelis J Stam; Fernando Maestú
Journal:  Front Aging Neurosci       Date:  2017-04-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.